Elyxium Wealth
VKTX icon

Elyxium Wealth’s Viking Therapeutics VKTX Stock Holding History

Elyxium Wealth’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$228 Buy
+7
New +$242 ﹤0.01% 1437

Other funds holding VKTX

Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Quantum Private Wealth
Quantum Private Wealth Tampa, Florida $391M AUM 50.76% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Lewis Asset Management
Lewis Asset Management Lafayette, California $294M AUM 25.62% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
MN Wealth Advisors
MN Wealth Advisors Overland Park, Kansas $247M AUM 16.11% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return

Elyxium Wealth's VKTX Position: Q3 2026 in Review

Elyxium Wealth opened a new position in Viking Therapeutics (VKTX) in Q3 2026: 7 shares worth $228. The stake represents ﹤0.01% of the portfolio and ranks #1437 among its holdings.

96 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.

  • Elyxium Wealth held 7 shares of Viking Therapeutics worth $228 as of Q3 2026.
  • Viking Therapeutics was a new Elyxium Wealth position in Q3 2026.
  • Viking Therapeutics made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #1437 holding.
  • 96 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.